ArticleScientific reports2019

DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain.

Laura Brandolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.